Just-published Apple patent signals aim to measure brain activity using AirPods sensor system

By SharpBrains | July 26, 2023

Apple Invents a next-gen­er­a­­tion Air­Pods Sen­sor Sys­tem that could mea­sure Biosig­nals and Elec­tri­cal Activ­i­ty of a User’s brain (Patent­ly Apple): Today the US Patent & Trade­mark Office pub­lished a patent appli­ca­tion from Apple that relates to a next-gen­er­a­­tion of Air­Pods Sen­sor Sys­tem where­in the hous­ing and tips of Air­Pods could include a num­ber of active and…

Read More

Should doctors prescribe Leqembi (lecanemab) to women with early Alzheimer’s Disease? The evidence-based answer is probably No

By SharpBrains | June 28, 2023

Wel­come to a new edi­tion of Sharp­Brains e‑newsletter, fea­tur­ing this time a range of inter­ven­tions for brain/ cognitive/ men­tal health plus a few brain teasers to test our per­cep­tion and cog­ni­tive skills. #1. Should doc­tors pre­scribe lecanemab (Leqem­bi) to women? The answer, giv­en avail­able evi­dence, is prob­a­bly No Huge (and most­ly over­looked) red flag regard­ing newly…

Read More

Study shows the power of electroencephalography and machine learning to help predict response to psychotherapy (or lack thereof) in patients with PTSD

By SharpBrains | May 2, 2023

A fas­ci­nat­ing study just pub­lished in Nature Men­tal Health aimed at help­ing pre­dict the out­comes of psy­chother­a­py for patients with Post-Trau­­mat­ic Stress Dis­or­der (PTSD) using Machine Learn­ing (ML) and elec­troen­cephalog­ra­phy (EEG) data. PTSD is a men­tal health con­di­tion trig­gered by expe­ri­enc­ing or wit­ness­ing a trau­mat­ic event; two evi­­dence-based treatments–Prolonged Expo­sure (PE) and Cog­ni­tive Pro­cess­ing Ther­a­py (CPT)–are…

Read More

Beacon Biosignals raises $27M to scale EEG, AI-based neurobiomarker discovery platform

By SharpBrains | November 17, 2021

Neu­rotech start­up Bea­con Biosig­nals scores $27M to bring AI to EEG analy­sis (Med­C­i­ty News): Elec­troen­cephalog­ra­phy is a decades-old tech­nique for cap­tur­ing brain activ­i­ty, data that are used to eval­u­ate brain dis­or­ders. Bea­con Biosig­nals is apply­ing arti­fi­cial intel­li­gence to these tests, and the neu­rotech­nol­o­gy start­up has found a ready mar­ket in phar­ma­ceu­ti­cal com­pa­nies inter­est­ed in assess­ing how…

Read More

Five thoughts to think about when thinking about the speed of thought

By The Conversation | September 21, 2021

As inquis­i­tive beings, we are con­stant­ly ques­tion­ing and quan­ti­fy­ing the speed of var­i­ous things. With a fair degree of accu­ra­cy, sci­en­tists have quan­ti­fied the speed of light, the speed of sound, the speed at which the earth revolves around the sun, the speed at which hum­ming­birds beat their wings, the aver­age speed of con­ti­nen­tal drift…. These…

Read More

Alphabet’s X shares Amber EEG system to expand the quest for mental health biomarkers

By SharpBrains | November 5, 2020

Alphabet’s X details Project Amber, a quest for a sin­gle bio­mark­er for depres­sion that fell short of its goal (TechCrunch): Alphabet’s X (the Google-owner’s so-called “Moon­shot Fac­to­ry”) pub­lished a new blog post today about Project Amber, a project it’s been work­ing on over the past three years — the results of which it’s now making…

Read More